Literature DB >> 10970920

Race, age, and back pain as factors in completion of residential substance abuse treatment by veterans.

K Stack1, J Cortina, C Samples, M Zapata, L F Arcand.   

Abstract

OBJECTIVE: Variables associated with successful completion of residential substance abuse treatment were identified.
METHODS: The records of 340 veterans admitted to a 120-day substance abuse treatment program were retrospectively analyzed. The likelihood of successful treatment completion was calculated as a function of race, age, gender, psychiatric diagnosis, past suicide attempts, homelessness, legal history, childhood physical or sexual abuse, parental history of addiction, multiple substance dependence, medical problems, and the race of the therapist. Univariate analysis and logistic regression analysis were used to identify variables that were significant predictors of treatment completion.
RESULTS: Overall, 66 percent of veterans completed the program. Eighty-two percent of the veterans admitted to the program were black, and 16 percent were white. The completion rate of black veterans (71 percent) was significantly higher than that of white veterans (49 percent). Veterans completing treatment were significantly more likely to be older, by an average of two years, than those who did not complete treatment. The association between younger age and failure to complete the program was largely accounted for by younger black veterans. Veterans with back pain were significantly less likely to complete treatment than those without back pain. Completion rates did not vary by the other variables examined. In the regression analysis that included age, race, and back pain, each variable, when adjusted by the other variables, was a significant predictor of completion.
CONCLUSIONS: White patients were less likely to complete residential substance abuse treatment in a program in which the majority of both therapists and patients were black. Younger black veterans and those with back pain were also less likely to complete treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10970920     DOI: 10.1176/appi.ps.51.9.1157

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  7 in total

1.  Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients.

Authors:  Kelly E Dunn; Patrick H Finan; D Andrew Tompkins; Michael Fingerhood; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2015-10-19       Impact factor: 4.492

2.  Moving Beyond Housing: Service Implications for Veterans Entering Permanent Supportive Housing.

Authors:  Taylor Harris; Hailey Winetrobe; Harmony Rhoades; Carl Andrew Castro; Suzanne Wenzel
Journal:  Clin Soc Work J       Date:  2018-01-22

3.  Does change in readiness influence retention among African American women and men in substance abuse treatment?

Authors:  LaTrice Montgomery; A Kathleen Burlew; Jeffrey E Korte
Journal:  J Ethn Subst Abuse       Date:  2017-04-03       Impact factor: 1.507

4.  Substance abuse and batterer programmes in California, USA: factors associated with treatment outcomes.

Authors:  Christine Timko; Helen Valenstein; Gregory L Stuart; Rudolf H Moos
Journal:  Health Soc Care Community       Date:  2014-12-03

5.  Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment.

Authors:  Declan T Barry; Mark Beitel; Dipa Joshi; Richard S Schottenfeld
Journal:  Am J Addict       Date:  2009 Mar-Apr

6.  Irregular hospital discharge from acute inpatient and residential mental health treatment settings in a large integrated healthcare system.

Authors:  Natalie B Riblet; Daniel J Gottlieb; Bradley V Watts; Maxwell Levis; Brian Shiner
Journal:  Gen Hosp Psychiatry       Date:  2021-06-26       Impact factor: 7.587

7.  Participation in a novel treatment component during residential substance use treatment is associated with improved outcome: a pilot study.

Authors:  Kathleen P Decker; Stephanie L Peglow; Carl R Samples
Journal:  Addict Sci Clin Pract       Date:  2014-05-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.